News

A new biotechnology and pharmaceutical industry commitment to patients and the public

Flightpath Biosciences, Inc is Selected to Participate in the Innovation Challenge at RESI Boston 2019

Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases

NEW

01-23-2020

Important! Fox Lyme Special Award Finalist, Vote it to the Top Now!

NEW

01-23-2020

New Study Finds Haemaphysalis longicornis Fails as Experimental Vector of Lyme Disease

NEW

01-21-2020

House Confirms Fiscal Year Spending 2020 for Lyme & Other Vector-Borne Diseases

NEW

01-20-2020

Rodent-Targeted Bait Vaccine Shows Decrease in Lyme Disease Transmission

NEW

01-16-2020

Commentary: Lyme disease led to my daughter’s death. Join the fight against tick-borne disease | CalMatters

NEW

01-15-2020